Lunch Talk Series with Dr. Marianna Spatola | Antibody-mediated pathogenic mechanisms in autoimmune encephalitis
Our upcoming Lunch Talk will be hosted by Dr. Eleonora Melzi, Group Leader (Team TAP) from BioMed X, and will feature Dr. Marianna Spatola, Research Group Leader and Director of the Neuro-Immune Crosstalk in Brain Infections and Autoimmunity (ImmuBRAIN) program at IDIBAPS-Hospital Clínic, University of Barcelona.
- Topic: Antibody-mediated pathogenic mechanisms in autoimmune encephalitis
- Location: K1/K2 Seminar Rooms, DKFZ Communication Center, Im Neuenheimer Feld 280, Heidelberg
- Date & Time: Tuesday, November 24, 2026 | 11:00 am – 12:30 pm
Lunch Talk Topic Description:
Autoimmune encephalitis encompasses a heterogeneous group of neurological disorders mediated by autoantibodies targeting neuronal surface proteins. These antibodies, predominantly of the IgG1 or IgG4 subclasses, exert their pathogenic effects through distinct mechanisms, including receptor internalization, as demonstrated in NMDAR encephalitis, and disruption of protein–protein interactions, as observed in LGI1 encephalitis.
In this seminar, she will provide an overview of the pathogenic mechanisms underlying autoimmune encephalitis, from in vitro studies to in vivo experimental models, including passive antibody transfer and active immunization approaches. Finally, she will present recent findings from her research investigating how antibody functional properties and their interactions with the innate immune system contribute to disease severity, clinical heterogeneity, and neurological outcomes.
About the Speaker:
Dr. Marianna Spatola, MD PhD, is a neurologist, Research Group Leader and Director of the Neuro-Immune Crosstalk in Brain Infections and Autoimmunity (ImmuBRAIN) program at IDIBAPS-Hospital Clínic, University of Barcelona. Her research investigates the mechanisms underlying autoimmune encephalitis, particularly how viruses trigger brain autoimmunity and how antibodies interact with innate immunity. Her recent work shows that antibody glycosylation patterns in the cerebrospinal fluid of people with anti-NMDAR encephalitis are linked to the cause of the disease and to recovery. She has also identified predictors of relapse and outcome in anti-GABAA receptor encephalitis. She leads a €1.5 million ERC Starting Grant (2025–2030) and an EU-funded project on microbiota and innate immune cells in autoimmune encephalitis. Her work is also supported by Spain’s Carlos III Health Institute and the La Caixa Foundation.
She obtained her MD from the University of Turin. She completed her Neurology residency and PhD at the University of Lausanne, co-directed by Prof Josep Dalmau of the University of Barcelona, and did postdoctoral research at Harvard University.
She is a Fellow of the American Academy of Neurology and Chair of the European Academy of Neurology’s Neuroimmunology Panel. Her awards include the University of Lausanne Faculty Prize, the AAN Top Science Prize and the International Neurovirology Society’s Neurovirology Lectureship Award.
We are looking forward to seeing you there!